Chemical Structure : IV-275
Catalog No.: PC-21073Not For Human Use, Lab Use Only.
IV-275 is a next-generation inhibitor of BRG1 and BRM bromodomains, inhibits SWI/SNF complex and enhances DNA damage and cell death in glioblastoma.
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
IV-275 is a next-generation inhibitor of BRG1 and BRM bromodomains, inhibits SWI/SNF complex and enhances DNA damage and cell death in glioblastoma.
IV-275 only enhances TMZ-induced death in GBM cells that express the BRG1 subunit, has no such effect in BRG1KO GBM cells.
IV-275 increases the amount of DNA-damage induced by TMZ and bleomycin.
IV-275 (20 uM, 24h) inhibits cell invasion and IFN-induced gene expression in MT330 and LN229 GBM cells.
IV-275 reduces the IFN-induced expression of CXCl11, increases IFN-induced expression of STAT1, IRF1 and IRF7 in GBM cell lines.
M.Wt | 360.36 | |
Formula | C19H18F2N2O3 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
1. Chuanhe Yang, et al. J Cell Mol Med. 2023 Aug 18.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright